BIM
DTIL icon

Bogle Investment Management’s Precision BioSciences DTIL Stock Holding History

Bogle Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,367
Closed -$609K – 341
2020
Q1 		$609K Buy
+3,367
New +$881K 0.06% 190

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bogle Investment Management's DTIL Position: Q2 2020 in Review

Bogle Investment Management sold out of Precision BioSciences (DTIL) in Q2 2020, closing a stake of 3,367 shares — an estimated $609K sold.

Bogle Investment Management first reported a position in DTIL in Q1 2020 and held it in 1 quarter. The position peaked at $609K in Q1 2020. 115 funds tracked by Wall St. Rank hold DTIL as of Q2 2020.

  • Bogle Investment Management reported no remaining Precision BioSciences position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 3,367 Precision BioSciences shares in Q2 2020, an estimated $609K.
  • Bogle Investment Management first reported a position in Precision BioSciences in Q1 2020 and held it in 1 quarter.
  • Bogle Investment Management's Precision BioSciences position peaked at $609K in Q1 2020.
  • 115 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.